This report examines the evolving field of assessing the health and cost effects of electronic nicotine delivery systems (ENDS), such as vaping devices, especially as access becomes more liberalized.
It emphasizes the importance of updated harm estimates relative to traditional cigarettes, which are crucial for informed policy-making and public health strategies.